19:13 WRAPX After Hours Summary: CRM +9.3% on earnings/guidance, TS +1.2% on earnings; F -0.8% (says credit arm will post lower profit in ‘08 vs. ‘07 — DJ) -Update-
Companies moving in after hours trading in reaction to earnings: Trading Up: CRM +9.3%; DBRN +12.7%; LSR +9.1%; FLS +9.8%; NKTR +8.4%; FIX +8.2%; VISN +7.1%; MIDD +6.6%; CTRP +6.2%; MANT +4.5%; NUVO +3.6%; AHT +3.1%; ZINC +3.1%; LTD +2.7%; GEF +2.6%; ARNA +2.2%; UHT +1.8%; TELK +1.6%; TS +1.2%; MRX +1.2%; MTZ +1.2%… Trading Down: SEED -32.9%; AIRN -17.2%; FIRE -12.1%; MYL -10.7%; DRCO -9.4%; RCKY -8.8%; ESPD -7.9%; AMSF -5.4%; GSIG -3.9%; GMR -3.0%; GMKT -2.9%; SWX -2.8%; CDR -1.7%… Companies moving in after hours trading in reaction to news: Trading Up: VRNM +17.0% (awarded U.S. Department of Energy grant to speed enzyme development for cellulosic ethanol production); IMMC +10.0% (announces FDA clearance of the CellSearch circulating tumor cell kit for monitoring patients with metastatic prostate cancer); REGN +8.5% (announces that the FDA approves co’s ARCALYST for treatment of cryopyrin-associated periodic syndromes); WPL +7.0% (has retained Merrill Lynch to review strategic alternatives; co postpones earnings release); APPX +1.9% (receives final approval for Irinotecan Hydrochloride Injection); ZGEN +1.8% (10% owner Warburg Pincus bought 243K shares at $9.02-9.73 on 2/21-2/26); SMHG +1.8% (to write down high-yield fund investment and increase loan loss reserves); DARA +1.0% (announces appointment of new director to board)… Trading Down: NGSX -33.0% (announces preliminary results from second Phase 3 clinical trial in HIV-DSP; primary and secondary endpoints do not achieve statistical significance); FIRE -12.1% (announces Wayne Jackson to step down as CEO; The board has initiated an external search process for a new CEO); DSTI -3.9% (CFO Raja Venkatesh resigns, effective March 14); SMOD -2.6% (Chief Financial Officer resigns); F -0.8% (says credit arm will post lower profit in ‘08 vs. ‘07 — DJ).
19:09 QCOM Qualcomm annonces International Trade Commission will not review administrative law judge’s initial determination in patent infringement complaint filed by Qualcomm against Nokia (43.79 +0.29) -Update-
Co announced that the International Trade Commission (ITC) will not review Administrative Law Judge Paul J. Luckern’s initial determination (ID) that Nokia’s GSM/GPRS/EDGE-only handsets (i.e., GSM/GPRS/EDGE handsets that do not also implement WCDMA) do not infringe three QCOM patents. The action relates to 2G products and is not related to Nokia’s (NOK) WCDMA or “3G” products that are at issue in other cases. Qualcomm will decide whether to appeal the ITC decision to the Court of Appeals for the Federal Circuit. Qualcomm filed a complaint against Nokia with the International Trade Commission in June 2006.
18:52 WG Willbros Group reports Q4 (37.09 +0.0
Reports Q4 (Dec) earnings of $0.16 per share, may not be comparable to the First Call consensus of $0.32; revenues rose 77.0% year/year to $337.5 mln vs the $283.1 mln consensus.
18:48 ARCI Appliance Recycling Cntrs announces Peter Hausback as Executive Vice President and CFO (6.94 +0.36)
Co announced that it has hired Peter Hausback for the newly created position of Executive Vice President and Chief Financial Officer. Hausback was most recently as Chief Financial Officer of Granite City Food & Brewery.
18:48 HT Hersha Hospitality Trust reports in-line; guides FY08 adjusted FFO’s in-line (9.14 +0.12)
Reports Q4 (Dec) earnings of $0.25 per share, in-line with the First Call consensus of $0.25; revenues rose 51.3% year/year to $61.4 mln vs the $57.2 mln consensus. Co sees FY08 adjusted funds from operations of $1.27-1.30 vs $1.30 consensus.
18:45 LHCG LHC Group reports EPS in-line, beats on revs; guides FY08 EPS below consensus, revs below consensus (21.51 +0.03)
Reports Q4 (Dec) earnings of $0.37 per share, excluding non-recurring items, in-line with the First Call consensus of $0.37; revenues rose 25.7% year/year to $81.3 mln vs the $80.3 mln consensus. Co issues downside guidance for FY08, sees EPS of $1.25-1.35 vs. $1.46 consensus; sees FY08 revs of $325-350 mln vs. $351.73 mln consensus.
18:41 PSA Public Storage beats by $0.09, beats on revs (80.48 -0.02)
Reports Q4 (Dec) funds from operations of $1.30 per share, $0.09 better than the First Call consensus of $1.21; revenues rose 7.1% year/year to $464.4 mln vs the $450.8 mln consensus.
18:25 NNN National Retail properties prices offering of convertible notes; common stock or a combination thereof at an initial conversion price of $25.42 per share (21.91 -1.11)
Co announced that it has priced its previously announced offering of convertible senior notes due 2028. The Co is selling $220 mln aggregate principal amount of notes at par with a coupon of 5.125%. The notes are convertible, subject to various conditions, into cash and at the Co’s option, cash, common stock or a combination thereof at an initial conversion price of $25.42 per share. The initial conversion price is equivalent to a conversion rate of 39.3459 shares per $1,000 principal amount of notes. Up to an additional $33 mln aggregate principal amount of notes may be issued pursuant to the underwriters’ over-allotment option within 30 days of the initial issuance of the notes. The offering is expected to close on March 4, 2008.
18:25 KVA KV Pharm reports Q3 EPS of $0.56 vs $0.33 yr ago; revs rise 38.8% to $163.7 mln (25.27 +0.27)
18:20 MTZ MasTec reports in-line; guides FY08 EPS and revs in-line; guides Q1 EPS below consensus, revs above consensus (7.98 -0.11) -Update-
Reports Q4 (Dec) earnings of $0.15 per share, in-line with the First Call consensus of $0.15; revenues rose 14.0% year/year to $273.6 mln vs the $260.2 mln consensus. Co issues in-line guidance; co sees FY08 EPS of $0.85-0.90 vs $0.86 consensus; sees $1.1-1.2 bln vs $1.1 bln consensus. Co issues downside EPS guidance; co sees Q1 EPS of $0.11-0.12 vs $0.15 consensus; sees revs of $250-260 mln vs $260.2 mln consensus. Co says, “The first quarter has historically been the Company’s softest quarter due to the slow beginning of our customers’ annual budget processes and general winter weather conditions, which prevent many activities and also reduce overall efficiency and productivity.”
18:17 DRCO Dynamics Research beats by $0.06, beats on revs; guides Q1 EPS below consensus, revs below consensus; guides FY08 EPS below consensus, revs below consensus (9.43 +0.44)
Reports Q4 (Dec) earnings of $0.26 per share, $0.06 better than the First Call consensus of $0.20; revenues fell 6.3% year/year to $56.5 mln vs the $55.9 mln consensus. Co issues downside guidance for Q1, sees EPS of $0.13-0.15 vs. $0.20 consensus; sees Q1 revs of $54-56 mln vs. $58.74 mln consensus. Co issues downside guidance for FY08, sees EPS of $0.74-0.84 vs. $0.87 consensus; sees FY08 revs of $220-235 mln vs. $243.67 mln consensus.
18:08 MIDD Middleby beats by $0.08, beats on revs (64.00 +1.92)
Reports Q4 (Dec) earnings of $0.89 per share, $0.08 better than the First Call consensus of $0.81; revenues rose 48.0% year/year to $145.5 mln vs the $133.3 mln consensus.
18:07 IMMC Immunicon announces FDA clearance of the CellSearch circulating tumor cell kit for monitoring patients with metastatic prostate cancer (0.90 +0.17)
Co announced that the FDA has cleared the CellSearch Circulating Tumor Cell (CTC) Kit as an aid in the monitoring of patients with metastatic prostate cancer. A sample of the patient’s blood is processed with the CellSearch Kit using the CellTracks System to capture and count CTCs. This clearance represents another expansion to claims for the kit, which is now cleared for three of the four most prevalent cancers.
18:06 GERN Geron misses by $0.04, beats on revs (5.17 +0.02)
Reports Q4 (Dec) loss of $0.22 per share, $0.04 worse than the First Call consensus of ($0.18); revenues rose 291.7% year/year to $4.7 mln vs the $3.3 mln consensus.
18:04 CTRP Ctrip.com beats by $0.06, beats on revs (54.65 -2.73)
Reports Q4 (Dec) earnings of $0.27 per share, $0.06 better than the First Call consensus of $0.21; revenues rose 58.1% year/year to $49 mln vs the $46 mln consensus. For FY08, the Co expects to continue the year-on-year net revenue growth at a rate of ~35%. .
18:00 REGN Regeneron Pharms announces that the FDA approves co’s ARCALYST for treatment of cryopyrin-associated periodic syndromes (18.90 +0.24) -Update-
Co announced it has received marketing approval from the U.S. Food and Drug Administration (FDA) for ARCALYST (rilonacept) Injection for Subcutaneous Use, an interleukin-1 blocker, for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome and Muckle-Wells Syndrome (MWS) in adults and children 12 and older. ARCALYST is the only therapy approved for patients with CAPS, a group of rare, inherited, auto-inflammatory conditions characterized by life-long, recurrent symptoms of rash, fever/chills, joint pain, eye redness/pain, and fatigue.
17:41 QCOM Qualcomm: Goldman Technology Conference Summary (43.79 +0.29)
On the Delaware litigation, the co thinks they are in a good position considering the contract. They note it starts in July, but thinks it’s a 2008 event in Phase I. Phase I could bring a lot of clarity to the decision… The co sees 3 players in mobile content: web cos, network service providers and handset OEMs. QCOM comes in to have platforms that all 3 can use, citing Brew doing well in content delivery. Co says the back office capability is the positive, whereas red share tax and closeness of the platform is the negative… On handsets at mini-pc stage, the co believes the trend is going towards the pc model. They see openness in platforms winning out because it’s more scaleable with just a couple o.s.’ not multiple… On Media flow, the co says the tech works extremely well, good clarity, uptime, and audio quality. They are learning about pricing, and believe that it needs to be more value based; thinking $15 is too high. Currently the tv content is 60% live, 40% time shifted until contracts are completed with the networks. Eventually they would like to get media flow into cars. They say the inflection point for media flow will be in 2010… Other growth drivers include mobile banking (need to get all the major banks signed), adding capability for gift cards digitally on mobile, mobile coupons, and the big payoff is proximity payments.
17:35 MKTIN Market Internals -Update-
The Dow was up 0.07% at 12694, the Nasdaq was up 0.37% at 2354, and the S&P was down 0.09% to close at 1380. Leading sectors included: Tires and Rubber +3.7%, Diversified Metals and Mining +3.0%, Homebuilding +3.0%, Office Electronics +2.6%, Trucking +2.4. Lagging sectors included: Independent Power Producers and Energy Traders –3.4%, Application Software –3.2%, Casinos and Gaming –3.1%, Wireless Services –2.9%, Coal and Consumable Fuels –2.8%. Today’s movement came from lower than avg volume (NYSE 1458, vs. 1605 avg, Nasdaq 2227, vs. 2313 avg), with decliners outpacing advancers (NYSE advance/decline 1504/1802, Nasdaq 1406/1519) with new lows outpacing new highs (NYSE new high/new low 65/75; Nasdaq 65/89.
17:31 AMSF Amerisafe misses by $0.04 (14.70 +0.27)
Reports Q4 (Dec) earnings of $0.92 per share, $0.04 worse than the First Call consensus of $0.96; revenues fell 14.6% year/year to $82.4 mln vs the $84.6 mln consensus. Outlook: For the full year 2008, the Co currently expects to produce a combined ratio of 94% or lower and a return on average equity of 15% or greater.
17:23 WLL Whiting Petroleum beats by $0.09, beats on revs (60.97 +0.12)
Reports Q4 (Dec) earnings of $1.08 per share, $0.09 better than the First Call consensus of $0.99; revenues rose 24.5% year/year to $232.4 mln vs the $221.1 mln consensus.
17:21 VVC Energy Systems Group signs $5.6 mln contract with world’s largest naval station (26.49 -0.42)
Co signed their first Utility Energy Services Contract (UESC), teaming up with Virginia Natural Gas, a subsidiary of AGL Resources, at Naval Station Norfolk, the world’s largest naval station. ESG will provide lighting, water, and mechanical system upgrades and will establish the framework for decentralization of the central steam system. In compliance with current energy legislation, these projects are designed to reduce energy, improve infrastructure, and address comfort concerns expressed by Naval Station Norfolk.
17:20 FLS Flowserve beats by $0.13, beats on revs; reaffirms FY08 EPS in-line (102.50 -0.94)
Reports Q4 (Dec) earnings of $1.36 per share, excluding $0.31 gain, $0.13 better than the First Call consensus of $1.23; revenues rose 25.6% year/year to $1.11 bln vs the $1.07 bln consensus. Co reaffirms in-line guidance for FY08, sees EPS of $5.10-5.40 vs. $5.15 consensus. FLS announces share repurchase program of up to $300 mln, and raises their quarterly dividend to $0.25, up from $0.15.
17:16 CLX Clorox announces pricing of $500 mln senior notes (59.59 -0.15)
Co announced that it has priced the offering of $500 mln aggregate principal amount of its 5.00 percent senior notes due 2013 in an underwritten registered public offering. The offering was made pursuant to an effective shelf registration statement Clorox filed with the Securities and Exchange Commission on Oct. 3, 2007. The offering is expected to close on March 3, 2008, subject to customary closing conditions. Clorox intends to use the net proceeds from the offering to retire commercial paper.
17:15 FIX Comfort Sys USA misses by $0.05, reports revs in-line; increases stock repurchase program, available to purchase back up to 1,000,000 shares (11.15 -0.7
Reports Q4 (Dec) earnings of $0.21 per share, $0.05 worse than the First Call consensus of $0.26; revenues rose 9.4% year/year to $293.3 mln vs the $291.4 mln consensus. Co increases stock repurchase program, available to purchase back up to 1,000,000 shares by authorizing the Co to acquire up to 712,083 additional shares of its outstanding common stock.
17:13 UHT Universal Health reports Q4 funds from operations of $0.59 vs $0.60 yr ago; revs fell 3.9% to $6.9 mln (33.01 -1.33)
17:13 SWX Southwest Gas reports Q4 EPS of $1.00 vs $1.08 First Call consensus; revs decreased 1% YoY $560.31 mln vs $510.25 mln First Call consensus (27.44 -0.05)
Co says “Two main factors prevented us from having a record year: lost operating margin resulting from warmer-than-normal weather, and a decline in the rate of customer growth due to the downturn in the housing market.”
17:12 FIX Increases Stock Repurchase Program, available to purchase back up to 1,000,000 shares by authorizing the Co to acquire up to 712,083 additional shares of its outstanding common stock
17:10 TGI Triumph Group announces acquisition of B&R Machine and Tool, expects to be immediately accretive to earnings (56.84 -0.3
Co announces the acquisition of the assets of B&R Machine and Tool, a manufacturer of aircraft structural components and dynamic parts and assemblies for commercial and military aerospace programs. The acquired business, which will operate as Triumph Structures-Long Island and be part of Triumph Aerospace Systems Group, is expected to add ~$45 mln of revenue for fiscal year 2009 and will be immediately accretive to earnings.
17:09 SU Suncor Energy announces plans to implement a two-for-one share split of its issued and outstanding common shares (103.67 0.00)
17:09 FIX prelim $0.21 vs $0.26 First Call consensus; revs $293.3 mln vs $291.43 mln First Call consensus
17:08 FLS Announces Share Repurchase Program of up to $300 Million
17:07 WLL prelim $1.08, incl items, may not be comparable to $0.99 First Call consensus; revs $232.4 mln vs $221.07 mln First Call consensus
17:03 F Ford says credit arm will post lower profit in ‘08 vs. ‘07 - DJ (6.60 +0.0
17:02 COKE Coca-Cola Bottling reports Q4 earnings (56.50 -1.5
Co lost $1.8 million, or basic net loss per share of $.19, in the fourth quarter of 2007 compared to net income of $8.6 million, or basic net income per share of $.94, in the fourth quarter of 2006. Net income in the fourth quarter of 2006 included the favorable impact of $4.9 mln, or basic net income per share of $.54, related to reduced income tax expense resulting from the settlement of tax positions with certain states.
17:00 STNR Steiner Leisure reports EPS in-line, beats on revs (31.87 -1.00)
Reports Q4 (Dec) earnings of $0.67 per share, in-line with the First Call consensus of $0.67; revenues rose 10.8% year/year to $135.2 mln vs the $132 mln consensus.
17:00 ESPD eSpeed misses by $0.05, reports revs in-line (12.10 -0.30)
Reports Q4 (Dec) loss of $0.04 per share, $0.05 worse than the First Call consensus of $0.01; revenues fell 15.1% year/year to $38.2 mln vs the $38.5 mln consensus. The Combined Company intends to pursue accretive acquisitions and to continue to profitably increase its brokerage headcount. It also expects to increase the percentage of its revs from fully electronic trading, Software Solutions and Market Data. The Combined Company believes that these developments would have a significant positive effect on its profit margins and revenues. The outlook for the Combined Company contained in this release does not include the potentially accretive impact of any of these developments. The Combined Company is expected to generate revs of approx $315 mln in the first quarter of 2008, up 15% from approx $273 mln in the prior year period. The Combined Company expects first quarter 2008 pre-tax income to increase by over 80% when compared to the year-ago quarter to the range of $46 mln to $49 mln.
17:00 CAM Cameron: Discloses Jack Moore has been named CEO, Charles Sledge has been named CFO; Authorizes the repurchase of 10 million shares (43.65 -1.04)
16:59 STNR prelim $0.67 vs $0.67 First Call consensus; revs $135.2 mln vs $132.00 mln First Call consensus
16:58 FLS prelim $1.67, incl items, may not be comparable to $1.23 First Call consensus; revs $1.11 bln vs $1.07 bln First Call consensus
16:55 ESPD prelim ($0.04) vs $0.01 First Call consensus; revs $38.2 mln vs $38.46 mln First Call consensus
16:51 ABH AbitibiBowater Earnings Preview (16.53 -0.26)
ABH is expected to report Q4 earnings tomorrow morning before the mkt open with a conference call to follow at 10AM ET… ABH Consensus: First Call Q4 EPS of ($2.67), revs of $1.65 bln; Q1 EPS of ($1.97), revs of $1.65 bln; FY07 EPS of ($7.41), revs of $5.24 bln; FY08 EPS of ($5.19), revs of $7.02 bln… Earnings History: This is the 2nd time the merged co (Abitibi and Bowater) is reporting earnings. The first time the results had a lot of noise… Expectations: Analysts are bullish on the co despite all of the problems it faces right now. The fundamentals look good due to the rising price of newspaper print (co has also raised its newsprint prices), rising price of coated groundwood (used for commercial printing), and the global reduction of global capacities. They are bullish even though it is a tough mkt as online advertising and a slowing US economy are sharply braking newsprint demand. The red flags also include ABH’s short-term liquidity issues as the co has debt due this summer, which has pressured the stock recently, according to some. In addition, the co has postponed earnings two times which has been received with some skepticism. Some other issues include “non-competitive” shipping prices for ABH, this is more of an issue than previously because of the increased exports. Additionally, analysts will be looking for the progress in creating synergies between the two cos… Areas of Focus on the Call: 1) Financing of near-term liquidity update 2) synergies color (how synergies of Abitibi and Bowater are progressing) 3) pricing of newsprint and commercial printing papers outlook… Technical Levels of Interest: Please see the Levels of Interest. Levels (Note that the length of horizontal line correlates with strength of support or resistance level) (PVIEW)
16:47 WPL WP Stewart has retained Merrill Lynch to review strategic alternatives; co postpones earnings release (3.74 -0.07)
The co announces the Board is reviewing strategic alternatives that could better position it to enhance long-term shareholder value. As part of this effort the co retained Merrill Lynch in late 2007 as its financial advisor. The co is currently in discussions with a number of parties; however, there can be no assurances these discussions will result in a successful conclusion. In the coming months the co will focus on rationalizing its expense base to reflect current market and co-specific conditions. As a result of this review of strategic alternatives and related discussions with third parties, it has become necessary to postpone releasing the co’s 2007 fourth quarter and year-end earnings results and the conference call scheduled for February 28 2008.
16:44 GM General Motors: Cerberus seeks FDIC waiver related to GMAC bank - DJ (24.82 +0.24) -Update-
16:44 AAPL Apple at Goldman Sachs Conference (122.88 +3.73)
Says guts tell them that there is something there for Apple TV; just shipped Apple2 a few weeks ago… says Macbook Air is a new category; believes iPod touch is a new category; says that they think Apple can do anything they want to; want to stay very focused on the businesses they have and may or may not add more busnesses… says demand for iPhone that the co is not is so intense that others are shipping out the iPhones and people are using other services; believes this is a sign of strong demand; says there will always be some level of hacking however they are seeing very few people in the U.S. have brought a phone to unlock it and use another service; says of all the problems look at this one with a smile as demand is so great… States they surpassed DELL as #1 supplier for portables to education facilities in 2007… says not really worried about competition as they are confident with their products.
16:44 SEED Origin Agritech reports FY07 net loss of $21.8 mln vs net income of $7.3 mln yr ago; revs fell 6.2% to $65.2 mln (9.60 -0.24)
Origin expects to report revenues range from US$75-$80 mln and bottom line range from a net income of US$0.5 mln-2 mln, for the fiscal year ending September 30, 2008. This net income figure is inclusive of roughly US$2.7 mln dollars in expected non-cash interest expense from our convertible debt offering. Exclusive of this non-cash expense, we expect a net income range of US$3.0-4.5 mln.
16:42 GOOD Gladstone Commercial reports Q4 FFO of $0.38 vs $0.38 consensus, revs rose 7% YoY to $8.9 mln vs $9 mln two analyst est (17.61 -0.39)
16:41 SEED Origin Agritech announces it has licensed a new genetically modified corn to officially introduce the next generation of corn product into China (9.60 )
16:39 SHS Sauer Danfoss reports Q4 earnings, issues FY08 guidance (23.58 )
Co reports Q4 EPS of $0.18 vs $0.21 single analyst estimate; revs rose 23% YoY to $494.2 mln vs $451.60 mln single analyst estimate. Sees FY08 $1.40-1.55 vs $1.65 single analyst estimate; sees revs up 7-9% YoY, or roughly $2.10-2.15 bln vs $2.08 bln single analyst estimate.
16:38 TYL Tyler Tech beats by $0.01, beats on revs; guides FY08 EPS in-line, revs above consensus (13.85 -0.01)
Reports Q4 (Dec) earnings of $0.15 per share, $0.01 better than the First Call consensus of $0.14; revenues rose 18.0% year/year to $60.4 mln vs the $58.8 mln consensus. Co issues mixed guidance for FY08, sees EPS of $0.49-0.53 vs. $0.51 consensus; sees FY08 revs of $259-265 mln vs. $254.43 mln consensus.
16:37 LTD Limited beats by $0.03, reports revs in-line; guides Q1 EPS in-line; guides FY09 EPS in-line (18.46 -0.1
Reports Q4 (Jan) earnings of $0.94 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.91; revenues fell 18.6% year/year to $3.28 bln vs the $3.26 bln consensus. Co issues in-line guidance for Q1, sees EPS of 0.05-0.10 vs. $0.13 consensus. Co issues in-line guidance for FY09, sees EPS of 1.35-1.55 vs. $1.49 consensus.
16:36 BEE Strategic Hotels & Resorts beats by $0.02, reports revs in-line; guides Q1 FFO in-line (15.83 +0.05)
Reports Q4 (Dec) funds from operations of $0.43 per share, $0.02 better than the First Call consensus of $0.41; revenues rose 10.9% year/year to $268.7 mln vs the $266.3 mln consensus. Co issues in-line guidance for Q1, sees FFO of $0.30-0.34 vs. $0.33 consensus. The co expects 1Q08 North American Total RevPAR growth to be in the range of 0.5%-1.5%, and first quarter 2008 RevPAR growth to be in the range of 1.5%-2.5%.
16:36 SMHG Sanders Morris Harris to write down high-yield fund investment and increase loan loss reserves (9.21 -0.54)
The co announces that it will write down the value of its high-yield hedge fund investment and increase loan reserves by approximately $5 million in the fourth quarter of 2007. The write downs stems from price declines in the bonds held by a high-yield hedge fund in which the co owns an interest and the loan loss reserves relate to investment banking-related loan commitments. By contrast, the 2007 pretax earnings of the co’s core asset/wealth mgmt businesses rose approximately 93% when compared to the prior year, subject to final audit confirmation. The co said it believes the credit quality of the vast majority of the high-yield fund’s underlying bonds is sound, and that their prices should improve to reflect that credit worthiness as debt mkts improve. “Our high-yield department has had an exemplary record over the years. Its credit selection discipline is well tested and we are comfortable with the future results of the fund. However, the turmoil in the debt markets has hurt all the participants in it,” said Ben Morris, CEO.
16:35 TYL sees FY08 $0.49-0.53 vs $0.51 First Call consensus; sees revs $259-265 mln vs $254.43 mln First Call consensus
16:35 TYL prelim $0.15 vs $0.14 First Call consensus; revs $60.4 mln vs $58.83 mln First Call consensus
16:35 DAR Darling International Inc beats by a penny; slightly misses on revs (13.55 -0.09)
Reports Q4 (Dec) earnings of $0.18 per share, $0.01 better than the First Call consensus of $0.17; revenues rose 37% year/year to $175.4 mln vs the $176.52 mln consensus.
16:35 PMII Power Medical Interventions misses by $0.60; guides FY08 revs in-line (13.81 +0.30)
Reports Q4 (Dec) ($1.21) $0.60 worse than the First Call consensus of ($0.61); revenues rose 5.6% year/year to $1.9 mln vs the $2.4 mln consensus. Co sees FY08 revs of $29-33 mln vs $30.0 mln consensus; co anticipates a loss from operations in 2008 of $23-25 mln. Co says, “a significant portion of the revenue growth is expected in the third and fourth quarters of 2008, as the company places more instruments with hospital accounts and reload firings increase.”
16:34 VISN VisionChina Media reports Q4 EPS of $0.10, ex-items, vs $0.07 in last qtr; revs up 495.2% yr/yr to $12.0 mln with no estimates (9.24 +0.09)
Co sees Q1 revs of $12.5-13.5 mln. Co sees Y08 revs of $90-94 mln.
16:33 ZGEN Zymogenetics: 10% owner Warburg Pincus bought 243K shares at $9.02-9.73 on 2/21-2/26 (9.75 -0.43)
16:33 LTD sees FY09 $1.35-1.55 vs $1.49 First Call consensus
16:33 LTD sees Q1 $0.05-0.10 vs $0.13 First Call consensus
16:32 House votes to repeal oil tax breaks, finance renewables - DJ
DJ reports the U.S. House of Representatives voted to repeal $18 bln of tax breaks for oil and gas producers and use the savings to finance tax incentives for wind-power projects, solar panels, and more energy-efficient cars. The bill passed by 236-182, but faces long odds amid opposition in the Senate and a White House veto threat. But it allowed House Democrats to promote renewable energy as an alternative to high-priced oil and to take aim at the oil industry, which is in the midst of a profit boom as prices keep rising. “We have the opportunity to invest in clean, renewable energy and energy efficiency and grow our economy, creating new jobs,” said House Speaker Nancy Pelosi, D-Calif.
16:32 LSR Life Sciences Research reports Q4 EPS of $0.63 vs $0.44 single analyst est, revs rose 20.9% YoY to $63.4 mln vs $62.42 mln single analyst est (23.00 -0.20)
16:32 LTD prelim $0.94 vs $0.91 First Call consensus; revs $3.28 bln vs $3.26 bln First Call consensus
16:31 DAR prelim $0.18 vs $0.17 First Call consensus; revs $175.4 mln vs $176.52 mln First Call consensus
16:30 GM General Motors to idle a plant Thursday due to Amer. Axle strike, source says - DJ (24.82 +0.24) -Update-
(AXL)
16:28 APPX APP Pharma receives final approval for Irinotecan Hydrochloride Injection (11.72 -0.07)
Co announces that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Irinotecan Hydrochloride Injection, 40 mg/2mL and 100mg/5mL, the generic equivalent of Camptosar Injection manufactured by Pfizer (PFE). Co has immediately commenced marketing and shipping the product. APPX’s irinotecan is AP-rated, bar-coded and latex-free. Sales of Camptosar in the United States were ~$556 mln in 2007.
16:28 NKTR Nektar Therapeutics reports Q4 (Dec) results, beats on revs (6.46 -0.26)
Reports Q4 (Dec) earnings of $0.42 per share, includes multiple gains, charges, may not be comparable to the First Call consensus of ($0.23); revenues fell 5.9% year/year to $65.8 mln vs the $42.9 mln consensus.
16:26 OSIP OSI Pharm seeks to strengthen Tarceva patent by filing re-issue application with the U.S. Patent and Trademark Office (37.81 +1.61)
Co announces that it has filed with the U.S. Patent and Trademark Office an application to reissue its composition of matter patent for Tarceva, U.S. Patent No. 5747498 in order to correct certain errors relating to the claiming of compounds, other than Tarceva, which fall outside of the scope of the main claim in the patent. OSIP’s reissue application seeks to correct these errors by deleting surplus compounds from the claims. Tarceva itself is accurately described in the patent. While the reissue application is pending, the patent remains listed in the Orange Book with the FDA and enforceable against any infringer.
16:26 NKTR prelim $0.42 may not be comparable to ($0.23) First Call consensus; revs $65.8 mln vs $42.89 mln First Call consensus
16:25 TECHX Equity markets finish mixed as Dow Industrials & Nasdaq Comp notch gains for the fourth consecutive session
The broad averages finished today’s session mixed as traders & investors digested myriad economic data & commentary. Jan. Durable Goods Orders came in below analysts forecasts @ -5.3% vs. -4.0% while Jan. News Home Sales were also lighter than forecast, coming in @ 580,000 vs. an expected 600,00. The headline economic event of the day was the start of Fed President Bernanke’s 2-day testimony to Congress on Capitol Hill. He touched on the hot topic of inflation saying upside risks to inflation greater than month ago but that expectations are ‘well anchored’. All of the major indices put in another higher low & higher high on the daily charts except for the Nasdaq 100 (NDX) which failed to breach yesterday’s 1763.40 intraday high. With more testimony scheduled tomorrow, unofficially, the INDU settled @ 12694.30 +9.35 or +0.05%, SPX @ 1380.00 -1.25 or -0.10%, COMPQ @ 2353.80 +8.80 or +0.35%, NDX @ 1799.95 +8.65 or +0.45%, & RUT @ 716.45 -0.90 or -0.10%. Sector strength in today’s session was noticeable in base Metals (DBB +3.65%), Semis (XSD +1.45%, SMH +1.2%), Broker/Dealers (IAI +0.90%), select Financials (IYF +0.50%, IYG +0.85%), & select Technology (QQQQ +0.50%). Sector weakness today was evident in select Utilities (-2.4%), Transportation (IYT -1.75%), select Commodities (GSG -1.7%, MOO -1.55%), Clean Energy (PBW -1.7%), and select Energy (USO -1.45%, OIH -1.4%).
16:25 GMR General Maritime misses by $0.03, reports revs in-line (24.54 -1.02)
Reports Q4 (Dec) earnings of $0.31 per share, $0.03 worse than the First Call consensus of $0.34; revenues rose 4.4% year/year to $55 mln vs the $54.9 mln consensus.
16:24 ATHX Athersys announces summary results for Phase 1 safety study of its novel obesity drug; ATHX-105 exhibits safety and tolerability (3.75 0.00)
Co announces top-line results from its Phase 1 clinical trial of ATHX-105, its orally administered drug candidate for the treatment of obesity. ATHX-105 was well-absorbed, providing good drug exposures, well-tolerated up to high doses, and had no negative effect on cardiovascular, hematology or other clinical parameters.
16:23 CDR Cedar Shopping Centers beats by $0.01, beats on revs; guides FY08 FFO in-line (11.90 +0.31)
Reports Q4 (Dec) funds from operations of $0.34 per share, $0.01 better than the First Call consensus of $0.33; revenues rose 26.8% year/year to $43 mln vs the $39.7 mln consensus. Co issues in-line guidance for FY08, sees FFO of $1.22-1.26 vs. $1.26 consensus. “The Co’s guidance excludes any impact on FFO from new or future development / redevelopment activities, any new acquisitions, dispositions, or from new joint venture arrangements of existing properties. The guidance anticipates throughout 2008 continuing stability in its tenant base, same store revenue growth of 1.4%, no significant change in the number of shares of common stock outstanding, an average 30-day LIBOR rate of 5.4%, and a net charge to FFO of $0.05 per share/OP Unit from the Homburg Invest Inc. joint venture.”
16:23 AHT Ashford Hospitality Trust reports EPS in-line, beats on revs (6.40 -0.10)
Reports Q4 (Dec) funds from operations of $0.30 per share, excluding non-recurring items, in-line with the First Call consensus of $0.30; revenues rose 144.6% year/year to $345.1 mln vs the $321.4 mln consensus.
16:22 GMR prelim $0.31 vs $0.34 First Call consensus; revs $54.97 mln vs $54.88 mln First Call consensus
16:22 GSIG GSI Group misses by $0.04, beats on revs; guides Q1 revs in-line (8.32 +0.01)
Reports Q4 (Dec) earnings of $0.11 per share, $0.04 worse than the 2 estimate consensus of $0.15; revenues rose 3.0% year/year to $86.5 mln vs the $81 mln single estimate. Co issues guidance for Q1, sees EPS of $0.02-0.06, includes charges, may not be comparable to $0.13 singel estimate; sees Q1 revs of $66-72 mln vs. $70.00 mln estimate.
16:22 AHT prelim funds from operations of $0.30 vs $0.30 First Call consensus; revs $345.1 mln vs $321.38 mln First Call consensus
16:21 EGLE Eagle Bulk Shipping reports EPS in-line, revs in-line (27.80 +0.57)
Reports Q4 (Dec) earnings of $0.35 per share, in-line with the First Call consensus of $0.35; revenues rose 25.4% year/year to $35.6 mln vs the $35.4 mln consensus.
16:20 FRX Forest Labs announces amendment to Bystolic Agreement; announces FRX will commercialize, develop and distribute Bystolic (42.52 +0.40)
The co announces that it and MYL have amended their January 2006 agreement to commercialize, develop and distribute the novel beta blocker Bystolic, which is currently approved in the United States for the treatment of hypertension. The cos have agreed that Forest will assume Mylan’s commercial rights for Bystolic in the United States and Canada including, but not limited to, the elimination of Mylan’s option to co-promote the product. Forest will be responsible for all future Bystolic development expenses as well as all sales and marketing expenses for the product. Under the terms of this amendment, Forest Laboratories Holdings will make a one-time cash payment of $370 million to Mylan. Forest will continue to pay Mylan its contractual royalties for three years, through calendar 2010, after which Forest will pay an amount consistent with the royalty rates Forest generally pays with respect to its principal products for the supply of active pharmaceutical ingredient. Beginning in the first quarter of calendar 2011 Forest will amortize the one-time cash payment over the remaining patent life of the product.
16:20 MDR McDermott beats by $0.05, beats on revs (53.00 +0.22)
Reports Q4 (Dec) earnings of $0.70 per share, $0.05 better than the First Call consensus of $0.65; revenues rose 16.7% year/year to $1.53 bln vs the $1.45 bln consensus.
16:18 MYL Mylan Labs reports Q4 (Dec) results, beats on revs (13.12 -0.15)
Reports Q4 (Dec) adjusted cash earnings of $0.11 per share, may not be comparable to the First Call consensus of ($0.05); revenues rose 187.5% year/year to $1.16 bln vs the $1.08 bln consensus. Co confirmes it expects to realize its stated $100 mln synergy target for the Merck Generics acquisition in 2008 and it is on track to meet or exceed the targeted recurring annual synergies of $300 mln by the end of 2010.
16:18 GEF Greif Brothers beats by $0.06, misses on revs; reaffirms FY08 EPS guidance (64.33 -1.42)
Reports Q1 (Jan) earnings of $0.81 per share, excluding non-recurring items, $0.06 better than the First Call consensus of $0.75; revenues rose 12.7% year/year to $846.3 mln vs the $940.7 mln consensus. Co reaffirms guidance for FY08, sees EPS of $3.80-4.00, excluding non-recurring items, vs. $3.97 consensus.
16:18 CDR reaffirms FY08 funds from operations of $1.22-1.26 vs $1.26 First Call consensus
16:17 MRX Medicis beats by $0.11, beats on revs; guides Q1 EPS below consensus, revs above consensus; guides FY08 EPS in-line, revs above consensus (19.77 -0.33)
Reports Q4 (Dec) earnings of $0.54 per share, $0.11 better than the First Call consensus of $0.43; revenues rose 41.6% year/year to $140.3 mln vs the $129.5 mln consensus. Co issues mixed guidance for Q1, sees EPS of $0.32-0.35 vs. $0.38 consensus; sees Q1 revs of $130-133 mln vs. $128.05 mln consensus. Co issues mixed guidance for FY08, sees EPS of $1.43-1.56 vs. $1.54 consensus; sees FY08 revs of $528-540 mln vs. $524.53 mln consensus.
16:17 CDR prelim funds from operations of $0.34 vs $0.33 First Call consensus; revs $43 mln vs $39.71 mln First Call consensus
16:17 DARA DARA BioSciences announces appointment of new director to board (4.90 +0.95)
Co announces the appointment of Haywood Cochrane to the Board of Directors effective February 21, 2008. Cochrane was appointed to fill a Board vacancy and will serve on the co’s Audit and Compensation Committees. Cochrane is currently Vice Chairman and a Director of I-trax (DMX).
16:16 MNI McClatchy reports 2008 January revenues (10.12 -0.25)
The co reports that consolidated revenues in January 2008 decreased 14.4% and advertising revenues were down 15.7% compared to revenues in January 2007.
16:16 MYL prelim $0.11 may not compare to ($0.05) First Call consensus; revs $1.16 bln vs $1.08 bln First Call consensus
16:15 EGLE prelim $0.35 vs $0.35 First Call consensus; revs $36 mln vs $35.40 mln First Call consensus
16:15 MDR prelim $0.70 vs $0.65 First Call consensus; revs $1.53 bln vs $1.45 bln First Call consensus
16:15 RCKY Rocky Brands misses by $0.22, misses on revs (6.20 +0.11)
Reports Q4 (Dec) loss of $0.02 per share, excluding non-recurring items, $0.22 worse than the First Call consensus of $0.20; revenues rose 2.7% year/year to $72.5 mln vs the $77.3 mln consensus.
16:15 NUVO Nuvelo beats by $0.05, misses on revs (1.71 +0.04)
Reports Q4 (Dec) loss of $0.22 per share, $0.05 better than the First Call consensus of ($0.27); revenues fell 93.1% year/year to $0.1 mln vs the $0.1 mln consensus.
16:14 MDR McDermott CEO Bruce Wilkinson announces that he will retire in 2008 (51.73 +0.22)
16:14 PHMD PhotoMedex reports Q4 EPS of $0.02 vs loss of ($0.01) a year ago qtr; revs rose 33% YoY to $11.4 mln (1.08 +0.00)
16:14 GSIG sees Q1 $0.02-0.06 vs $0.13 single analyst est; sees revs $66-72 mln vs $70.00 mln single analyst est
16:14 SDBT SoundBite Communications reports Q4 results; guides Q1 and FY08 (5.05 -0.04) -Update-
Co reports Q4 EPS of $0.04 vs $0.00 First Call consensus; revs $11.3 mln vs $10.75 mln First Call consensus. Co sees Q1 revs $10.7-11 mln vs $10.45 mln First Call consensus. sees FY08 revs $53.3-55.3 mln vs $52.28 mln First Call consensus
16:14 AKRX Akorn initiated with an Outperform at Credit Suisse; tgt $10 - Bloomberg (6.58 -0.26)
16:13 TS Tenaris beats by $0.21, beats on revs (44.00 +0.24)
Reports Q4 (Dec) earnings of $0.93 per share, $0.21 better than the First Call consensus of $0.72; revenues rose 6.8% year/year to $2.63 bln vs the $2.59 bln consensus. Co states. “We expect our sales to increase in 2008, led by higher sales of specialized, high-end OCTG products, and that the increase in sales should result in higher operating and net income. However, increased volatility in economic conditions and raw material and commodity prices could affect market conditions for our products and services and, consequently, our results for the
second half of the year.”
16:13 GSIG prelim $0.11 vs $0.15 two analyst est; revs $86.5 mln vs $81.00 mln single analyst est
16:12 DBRN Dress Barn beats by $0.03, reports revs in-line; reaffirms FY08 EPS above consensus (12.56 -0.34)
Reports Q2 (Jan) earnings of $0.09 per share, excluding $0.03 benefit, $0.03 better than the First Call consensus of $0.06; revenues rose 1.6% year/year to $345.6 mln vs the $343 mln consensus. Co reaffirms upside guidance for FY08, sees EPS of $1.05-1.10 vs. $1.02 consensus.
16:12 SDBT sees FY08 revs $53.3-55.3 mln vs $52.28 mln First Call consensus
16:11 DAVE Famous Dave’s reports EPS in-line, beats on revs; lowers new store opening guidance (10.98 +0.91)
Reports Q4 (Dec) earnings of $0.06 per share, excluding non-recurring items, in-line with the First Call consensus of $0.06; revenues rose 12.2% year/year to $31.4 mln vs the $30.1 mln consensus. Co said, “Given the longer development timelines we are seeing across the country, and the current softness in the economy, we are tempering our guidance on new restaurant openings for 2008 to a range of 20 to 25 total restaurants, from a previous range of 25 to 30 locations, with up to 6 of the expected openings to be company-owned restaurants”.
16:11 ZINC Horsehead Holding reports Q4 EPS of $0.55, ex items, vs $0.46 First Call consensus; revs rose 10% YoY to $119.2 mln vs $117.28 mln First Call consensus (16.97 +0.7
“Our capacity expansion projects continue to be on schedule. The Rockwood, Tennessee waelz kiln, which we brought on-line at the beginning of 2008, is expected to ramp up during the first quarter. Engineering, site selection and incentive negotiations are underway for a new EAF dust processing facility in the Carolinas. This, along with other projects, will enable us to use more low-cost feed for zinc production. We also expect to bring 10,000 additional tons of zinc oxide capacity on-line during the second quarter of 2008… We have hedged 90,000 tons of zinc for 2008, representing approximately 60% of our expected zinc production, through the purchase of put options with a strike price of $1.00 per pound. In the event of a decline in zinc prices, we expect these hedges to help ensure an adequate level of cash flow from operations. We have also hedged 45,000 tons of zinc for 2009 thus far, through the purchase of put options with a strike price of $0.90 per pound. These hedges will allow us to participate in any increase in the price of zinc while protecting us if the zinc price declines below the strike prices.”
16:11 FIRE Sourcefire misses by $0.04, misses on revs; issues Q1 guidance (6.52 +0.05)
Reports Q4 (Dec) earnings of $0.10 per share, excluding non-recurring items, $0.04 worse than the First Call consensus of $0.14; revenues rose 20.6% year/year to $19.3 mln vs the $20 mln consensus. Co issues guidance for Q1, sees EPS of ($0.14)-($0.11), includes stock based compensation, may not be comparable to ($0.03) consensus; sees Q1 revs of $12-12.5 mln vs $12.77 mln consensus.
16:11 CWT California Water reports Q4 EPS of $0.39 vs $0.33 consensus, revs rose 6.5% YoY to $85.9 mln vs $86.15 mln consensus (36.64 -0.1
16:11 SDBT sees Q1 revs $10.7-11 mln vs $10.45 mln First Call consensus
16:11 XETA Xeta Tech reports Q4 results; reaffirms 2Q08 and FY08 EPS guidance (4.25 +0.00)
Reports Q4 (Dec) EPS of $0.04 per share (no est); vs $0.02 a year ago; revenues rose 11% year/year to $17.9 mln. Co reaffirms its Q2 EPS of $0.03-$0.05 (no est) and its FY08 guidance of EPS of $0.22-$0.28.
16:10 GEF sees FY08 $3.80-4.00, excluding $0.35 gain, vs $3.97 First Call consensus
16:10 SDBT prelim $0.04 vs $0.00 First Call consensus; revs $11.3 mln vs $10.75 mln First Call consensus
16:09 FIRE sees Q1 ($0.14-0.11) may not compare to ($0.03) First Call consensus; sees revs $12-12.5 mln vs $12.77 mln First Call consensus
16:09 CRM Salesforce.com beats by $0.02, beats on revs; guides Q1 EPS in-line, revs above consensus; guides FY09 EPS in-line, revs above consensus (52.62 -0.14)
Reports Q4 (Jan) earnings of $0.06 per share, $0.02 better than the First Call consensus of $0.04; revenues rose 50.4% year/year to $216.9 mln vs the $209.2 mln consensus. Co issues mixed guidance for Q1, sees EPS of $0.06-0.07 vs. $0.06 consensus; sees Q1 revs of $233-235 mln vs. $228.54 mln consensus. Co issues mixed guidance for FY09, sees EPS of $0.32-0.33 vs. $0.33 consensus; sees FY09 revs of $1.030-1.035 bln vs. $1.03 bln consensus.
16:09 GEF prelim $1.16, excl items, may not be comparable to $0.75 First Call consensus; revs $846.3 mln vs $940.66 mln First Call consensus
16:09 FIRE prelim $0.10 vs $0.14 First Call consensus; revs $19.3 mln vs $20.00 mln First Call consensus
16:09 TKC prelim revs $1.81 bln vs $1.76 bln First Call consensus
16:09 MRX sees FY08 $1.43-1.56 vs $1.54 First Call consensus; sees revs $528-540 mln vs $524.53 mln First Call consensus
16:09 MRX sees Q1 $0.32-0.35 vs $0.38 First Call consensus; sees revs $130-133 mln vs $128.05 mln First Call consensus
16:08 FIRE Sourcefire announces Wayne Jackson to step down as CEO; The board has initiated an external search process for a new CEO (6.54 +0.07)
16:08 WJCI WJ Comms reports Q4 EPS of ($0.01) vs ($0.02) First Call consensus; revs $10.6 mln vs $11.00 mln First Call consensus (0.74 -0.01)
16:08 NGSX Neurogesx announces preliminary results from second Phase 3 clinical trial in HIV-DSP; primary and secondary endpoints do not achieve statistical significance (5.97 -0.11)
Co announces preliminary top-line results from study C119, its second Phase 3 clinical trial of NGX-4010, the co’s dermal patch drug candidate, in patients with HIV-distal sensory polyneuropathy. The prespecified analysis of the primary endpoint, comparing all patients treated with NGX-4010 compared to all patients treated with the control patch, did not meet statistical significance with the overall NGX-4010 treatment group achieving a 29.5% reduction in pain from baseline over weeks 2-12 compared to a 24.6% reduction for the control group. The results were confounded by a much higher than anticipated control group response overall and, in particular, in the 60-minute control arm. NeurogesX intends to enter into commercial partnerships for marketing and distribution outside the United States. Co expects to submit an NDA with the FDA in the second half of 2008 for PHN and will discuss with the agency the path forward for attaining approval for HIV- DSP.
16:08 MRX prelim $0.54, ex items vs $0.43 First Call consensus; revs $140.3 mln vs $129.51 mln First Call consensus
16:07 MANT ManTech beats by $0.03, beats on revs; guides Q1 EPS above consensus, revs above consensus; guides FY08 EPS in-line, revs in-line (44.97 +0.61)
Reports Q4 (Dec) earnings of $0.61 per share, $0.03 better than the First Call consensus of $0.58; revenues rose 45.1% year/year to $421.8 mln vs the $410.9 mln consensus. Co issues upside guidance for Q1, sees EPS of $0.56-0.59 vs. $0.53 consensus; sees Q1 revs of $425-435 mln vs. $400.57 mln consensus. Co issues in-line guidance for FY08, sees EPS of $2.34-2.46 vs. $2.37 consensus; sees FY08 revs of 1.725-1.785 bln vs. $1.75 bln consensus. ManTech’s first quarter 2008 revenue guidance represents total revenue growth of 44% to 48% and pro forma organic revenue growth of 19% to 22%. ManTech’s 2008 full year revenue guidance represents total revenue growth of 19% to 23% and pro forma organic revenue growth of 10% to 13% without any future acquisitions.
16:07 SDBT SoundBite Communications acquires Mobile Collect for approx $500k plus additional contingent consideration of up to $2 million (5.05 -0.04)
16:07 ARNA Arena Pharm beats by $0.18, misses on revs (6.93 -0.04)
Reports Q4 (Dec) loss of $0.60 per share, $0.18 better than the First Call consensus of ($0.78); revenues fell 2.1% year/year to $4.6 mln vs the $4.8 mln consensus. Co expects to use cash, cash equivalents and short-term investments of approx $190-210 mln for its operating activities in 2008 and approx $38-44 mln for capital expenditures.
16:06 DSTI DayStar Technologies CFO Raja Venkatesh resigns, effective March 14 (3.60 +0.01)
Chris Lail, DayStar’s controller, will serve in the interim while the company completes its search for a new CFO.
16:06 CRM sees FY09 $0.32-0.33 vs $0.33 First Call consensus; sees revs $1.030-1.035 bln vs $1.03 bln First Call consensus
16:06 STAK Staktek Holdings misses by $0.01, misses on revs; guides for Q1 (1.55 +0.01)
Reports Q4 (Dec) loss of $0.02 per share, excluding non-recurring items, $0.01 worse than the single estimate of ($0.01); revenues fell 7.1% year/year to $13 mln vs the $13.7 mln single estimate. Co sees Q1 EPS of $8-10 mln, no estimates
16:06 DAVE prelim $0.06 vs $0.06 First Call consensus; revs $31.4 mln vs $30.10 mln First Call consensus
16:06 WSII Waste Services reports Q4 revs of $130.1 mln vs $124.6 mln consensus;sees FY08 EPS of $0.30-0.35, which may not be comparable to the $0.28 consensus, sees FY08 revs of $480-500 mln, which may not be comparable to the $531 mln two analyst est (8.68 -0.15)
16:06 SMOD Smart Modular Tech Chief Financial Officer resigns (7.17 -0.10)
Co announces that its Senior Vice President and Chief Financial Officer, Jack Pacheco, will leave effective April 18, 2008, to take a position with a privately held company in a different industry. The co expects to retain an executive search firm to identify a successor to Pacheco. MacKenzie will serve as acting CFO on an interim basis until a well-qualified replacement is appointed.
16:06 CRM sees Q1 $0.06-0.07 vs $0.06 First Call consensus; sees revs $233-235 mln vs $228.54 mln First Call consensus
16:06 TELK Telik reports Q4 EPS of ($0.25) vs ($0.24) First Call consensus (2.64 -0.16)
Co also announces its financial guidance for 2008. Telik is forecasting total operating expenses of approx $52 mln, which includes approx $8.5 mln in stock-based compensation expense. This represents a decrease of approx $8 mln in operating expenses as compared with the year ended December 31, 2007, and reflects the co’s focus on the Phase 2 clinical trials of TELINTRA Tablets, preclinical studies on TLK58747 and reduced development of TELCYTA. The stock-based compensation expense estimate is dependent on market price assumptions used in estimating the fair value and the levels of share-based payments. Telik is forecasting net cash utilization in 2008 of approx $45 mln.
16:05 AIRN Airspan Networks misses by $0.06, reports revs in-line; guides Q1 revs in-line (1.42 +0.01)
Reports Q4 (Dec) loss of $0.14 per share, $0.06 worse than the First Call consensus of ($0.08); revenues rose 5.8% year/year to $23.8 mln vs the $23.9 mln consensus. Co issues in-line guidance for Q1, sees Q1 revs of $20-21 vs. $25.46 mln consensus. “Our WiMAX revenue was up 40% in 2007 over 2006. As a result, today Airspan is the leading U.S. based pure-play WiMAX equipment supplier and our market share position has been recognized by leading market research analysts like Maravedis… The telecom equipment sector traditionally experiences seasonality with a lighter first quarter than the previous year’s fourth quarter and we are anticipating that same trend for our business.
16:05 TS prelim $0.93 vs $0.72 First Call consensus; revs $2.63 bln vs $2.59 bln First Call consensus
16:05 CRM prelim $0.06 vs $0.04 First Call consensus; revs $216.9 mln vs $209.19 mln First Call consensus
16:04 BAGL Einstein Noah reports Q4 (Dec) results, beats on revs (16.40 +0.79)
Reports Q4 (Dec) earnings of $0.41 per share, includes multiple items, may not be comparable to the First Call consensus of $0.44; revenues rose 6.1% year/year to $105.2 mln vs the $103.8 mln consensus.
16:04 MANT sees FY08 $2.34-2.46 vs $2.37 First Call consensus; sees revs $1.725-1.785 bln vs $1.75 bln First Call consensus
16:04 CFI prelim $0.11, ex-items, vs $0.09 First Call consensus; revs $60.5 mln vs $56.78 mln First Call consensus
16:03 ARNA prelim ($0.60) vs ($0.7
First Call consensus; revs $4.6 mln vs $4.77 mln First Call consensus
16:03 MANT sees Q1 $0.56-0.59 vs $0.53 First Call consensus; sees revs $425-435 mln vs $400.57 mln First Call consensus
16:03 NWK Network Equip announces $20 million stock buyback program (6.24 -0.20)
16:03 DBRN reaffirms FY08 $1.05-1.10 vs $1.02 First Call consensus
16:03 DR prelim $0.64 vs $0.46 First Call consensus
16:03 GMKT GMarket beats by $0.03, misses on revs (22.85 -0.14)
Reports Q4 (Dec) earnings of $0.26 per share, $0.03 better than the First Call consensus of $0.23; revenues rose 39.2% year/year to $71.8 mln vs the $72.8 mln consensus.
16:03 STAK sees Q1 revs $8-10 mln
16:02 NUVO prelim ($0.22) vs ($0.27) First Call consensus; revs $0.1 mln vs $0.08 mln First Call consensus
16:02 MANT prelim $0.61 vs $0.58 First Call consensus; revs $422 mln vs $410.93 mln First Call consensus; this is in-line with their recent pre-announcement
16:02 DBRN prelim $0.09 vs $0.06 First Call consensus; revs $345.6 mln vs $343.02 mln First Call consensus
16:02 ACAS American Capital arranges $75 mln in recapitalization and add-on acquisition financing for portfolio company Tanenbaum-Harber (37.84 +1.12)
Co announces that in December 2007 it arranged the $75 million recapitalization of its portfolio company Tanenbaum-Harber Holdings, an insurance brokerage and risk management consulting firm. The recapitalization supports the refinancing of a portion of Tanenbaum-Harber’s existing debt as well as TH’s second add-on acquisition. American Capital’s investment takes the form of a revolving credit facility, term loan and preferred and common equity.
16:02 STAK prelim ($0.02) ex items note comparable to ($0.01) single analyst est; revs $13 mln vs $13.70 mln single analyst est
16:01 AIRN sees Q1 revs $20-21 mln vs $25.46 mln First Call consensus
16:01 AIRN prelim ($0.14) vs ($0.0
First Call consensus; revs $23.8 mln vs $23.85 mln First Call consensus
16:01 RCKY prelim ($0.02), may not be comparable to $0.20 First Call consensus; revs $72.5 mln vs $77.27 mln First Call consensus
16:00 AVID Avid Tech announces authorization of additional funds for stock repurchase program of $100 mln (24.60 +0.94)
16:00 GMKT prelim $0.26 vs $0.23 First Call consensus; revs $71.8 mln vs $72.84 mln First Call consensus
16:00 VRNM Verenium awarded U.S. Department of Energy grant to speed enzyme development for cellulosic ethanol production (9.30 +0.07)
The co announces that it has been awarded one of four grants from the U.S. Department of Energy under a $33.8 mln program announced yesterday for the development of improved enzyme systems to be used in converting biomass into clean, renewable cellulosic ethanol. The grants will be appropriated over a four-year period beginning now through 2011.
16:00 BAGL prelim $0.41 vs $0.44 First Call consensus; revs $105.2 mln vs $103.81 mln First Call consensus